– USA, CA – OncoMed Pharmaceuticals, Inc. (Nasdaq:OMED), a clinical-stage company developing novel therapeutics that target cancer stem cells (CSCs), or tumor-initiating cells, today announced the appointment of independent director Michael Wyzga to the company’s Board of Directors.…
– UK, London – ValiRx Plc (AIM: VAL), a life science company with a focus on cancer diagnostics and personalised therapeutic development announces the following board changes:
Seppo Mäkinen has more than 25 years of senior advisory and executive experience in board level strategic leadership and venture capital management on life science.…
– USA – New York – Keryx Biopharmaceuticals, Inc. (Nasdaq:KERX) today announced the appointment of Daniel P.…
– USA – Natick, MA – Karyopharm Therapeutics Inc., a clinical-stage pharmaceutical company focused on developing novel first-in-class drugs directed against nuclear transport targets for the treatment of cancer and other major diseases, today announced the appointment of Garen Bohlin to its board of directors, effective immediately.…
ROCKVILLE, MD, USA – MacroGenics, Inc. today announced its Board of Directors has elected Paulo F.…